MedTrace Logo

Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women

NCT07259525 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2025-12-22

No results posted yet for this study

Summary

This observational cross-sectional case-control study aims to evaluate the effects of menopausal status on escitalopram metabolism in women. The study will include premenopausal and menopausal women aged 40-60 years who are currently receiving escitalopram treatment and have applied to the Psychiatry Clinic of Eskişehir Osmangazi University. The study aims to identify pharmacokinetic differences associated with hormonal status and to investigate their potential clinical implications. Findings from this research are expected to contribute to the development of evidence-based, individualized treatment strategies for women in menopausal transition.

Conditions

  • Therapeutic Drug Monitoring (TDM)
  • Menopause
  • Depression - Major Depressive Disorder
  • General Anxiety Disorder

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Eskisehir Osmangazi University

    lead OTHER

Principal Investigators

  • İmran G Yılmaz Karaman, Associtate Professor Doctor · Eskişehir Osmangazi University, Faculty of Medicine

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2028-01-31
Completion
2028-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07259525 on ClinicalTrials.gov